IRD
IRD
US67577R1023
Opus Genetics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
386.86M EUR
339.68M EUR
324.88M EUR
140.49M EUR
Enterprise Value
318.45M EUR
287.08M EUR
266.12M EUR
96.53M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-6.5x
--
--
--
Price to Sales
39.25x
34.46x
27.11x
14.3x
Price to Book
--
--
--
9.15x
EV/Revenue
32.31x
29.13x
22.21x
9.82x
EV/EBITDA
-6.3x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.97%
-11.97%
-12%
-18.69%
ende